SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-012033
Filing Date
2022-08-04
Accepted
2022-08-04 07:01:00
Documents
58
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q elev-20220630x10q.htm   iXBRL 10-Q 1972547
2 EX-31.1 elev-20220630xex31d1.htm EX-31.1 11001
3 EX-31.2 elev-20220630xex31d2.htm EX-31.2 10893
4 EX-32 elev-20220630xex32.htm EX-32 7543
  Complete submission text file 0001558370-22-012033.txt   6264330

Data Files

Seq Description Document Type Size
5 EX-101.SCH elev-20220630.xsd EX-101.SCH 37223
6 EX-101.CAL elev-20220630_cal.xml EX-101.CAL 30771
7 EX-101.DEF elev-20220630_def.xml EX-101.DEF 142688
8 EX-101.LAB elev-20220630_lab.xml EX-101.LAB 384453
9 EX-101.PRE elev-20220630_pre.xml EX-101.PRE 279214
52 EXTRACTED XBRL INSTANCE DOCUMENT elev-20220630x10q_htm.xml XML 906949
Mailing Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106
Business Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106 212-651-6380
Elevation Oncology, Inc. (Filer) CIK: 0001783032 (see all company filings)

IRS No.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40523 | Film No.: 221134569
SIC: 2836 Biological Products, (No Diagnostic Substances)